Ramky Infrastructure Eyes ₹13,000 Cr Order Book, ₹250+ Cr PAT for FY26

INDUSTRIAL-GOODSSERVICES
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
Ramky Infrastructure Eyes ₹13,000 Cr Order Book, ₹250+ Cr PAT for FY26
Overview

Ramky Infrastructure anticipates a strong fiscal year 2026, forecasting a consolidated order book of ₹13,000 crore and Profit After Tax (PAT) exceeding ₹250 crore. However, this PAT figure includes a significant one-time gain from selling a stake in Visakha Pharma City Ltd.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Ramky Infrastructure Charts Robust FY26 Outlook

Ramky Infrastructure Limited has outlined its financial projections for fiscal year 2025-2026, revealing a substantial consolidated order book valued at ₹13,000 crore. The standalone order book is projected at ₹9,500 crore. For the same period, the company anticipates consolidated revenue of ₹1,846 crore and standalone revenue of ₹1,679 crore. Both standalone and consolidated Profit After Tax (PAT) are expected to surpass ₹250 crore, with a notable portion attributed to an exceptional gain from the divestment of an equity stake in Visakha Pharma City Ltd.

Key Financial Indicators for FY26 Projections:

  • Consolidated Order Book: ₹13,000 crore
  • Standalone Order Book: ₹9,500 crore
  • Consolidated PAT: ₹250+ crore (includes exceptional gain)
  • Standalone PAT: ₹250+ crore (includes exceptional gain)
  • Consolidated Revenue: ₹1,846 crore
  • Standalone Revenue: ₹1,679 crore

Investor Insight and Financial Discipline

This forward-looking update provides investors with a clear view of Ramky Infrastructure's expected revenue streams and overall financial standing. The large order backlog suggests consistent business activity. On the standalone front, the company highlights its financial prudence with zero term debt, a positive sign for its balance sheet strength. Nevertheless, the inclusion of an exceptional item in PAT requires careful examination to understand the underlying profitability from core operations.

Strategic Project Wins Fuel Growth

Ramky Infrastructure has demonstrated a strong ability to secure significant infrastructure contracts. Recent successes include landing a ₹3,000 crore Life Sciences City project, a ₹2,085 crore water transmission project for HMWSSB, and an ₹1,401 crore EPC and Operations & Maintenance contract. These key wins are instrumental in building the current order book and ensuring future project execution.

Strong Order Inflows Position Company for Activity

The company reports substantial order inflows for FY25-26, with ₹6,500 crore consolidated and ₹3,000 crore standalone. This influx, combined with the existing backlog, positions Ramky Infrastructure for sustained operational momentum. The emphasis on strengthening its balance sheet, particularly the zero term debt on a standalone basis, underscores a strategic financial management approach.

PAT Composition Requires Scrutiny

Investors should pay close attention to the components driving the projected PAT. The substantial gain from selling the Visakha Pharma City Ltd stake is a one-time event. It is crucial for investors to differentiate this non-recurring income from the company's regular operational earnings to accurately assess its sustainable performance.

Financial Metrics and Competitive Edge

While specific peer comparisons for FY26 projections were not detailed, Ramky Infrastructure's standalone nil term debt stands out as a strong financial metric. The consolidated operations carry ₹160 crore in term debt. The company's proven capability in securing large-scale projects, particularly in water transmission and urban development, serves as a key competitive advantage.

Tracking Future Progress

Moving forward, investors will want to closely follow the execution progress of major projects, including the Life Sciences City and HMWSSB water transmission projects. Monitoring the consistency of order inflows and the company's capacity to generate profits from its core business, independent of exceptional gains, will be vital for assessing its long-term trajectory.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.